Scientists launch new trial for long COVID treatment Podcast Por  arte de portada

Scientists launch new trial for long COVID treatment

Scientists launch new trial for long COVID treatment

Escúchala gratis

Ver detalles del espectáculo

Obtén 3 meses por US$0.99 al mes + $20 crédito Audible

Scientists at Scripps Research recently launched a new clinical trial that will test if a repurposed GLP-1 drug, tirzepatide, can provide possible relief for long COVID symptoms.Monday on Midday Edition, we sit down with Dr. Eric Topol to hear more about the trial and the state of long COVID research and treatment today.Guest:Dr. Eric Topol, executive vice president, Scripps Research Translational InstituteResources: Long COVID Treatment Trial — Scripps Research

Todavía no hay opiniones